FAQs about the GeneSight Test
About the GeneSight Test
Your genes are unique to you. You and a family member may respond or react differently to the same medication. The GeneSight test uses your genetic information to provide options for your doctor.
If you have struggled with depression medication, your genes may be a contributing factor. With the GeneSight test, your genetic makeup can provide clinicians with insight into how you may metabolize or respond to certain depression medications.
The GeneSight test must be ordered by your doctor or nurse practitioner. The test is a simple cheek swab taken in your health care provider’s office or in the convenience of your home.
How to Take the Test
A healthcare provider is critical as patients should never change prescription medications on their own. The GeneSight test is intended to supplement other information considered as part of a comprehensive medical assessment, like potential drug/drug interactions, age, weight, lifestyle, etc.
Yes, your doctor or nurse practitioner can order the GeneSight test and have the collection kit sent directly to your home. You would then collect your sample by swabbing the inside of your cheeks, sign the patient consent form, and ship both back in the pre-paid FedEx envelope included in the kit.
No, since a person’s genes will not change based on what medications they are taking, the GeneSight results will not change. Please talk with your healthcare provider before making any medication changes.
The GeneSight test results will be accurate for any age because a person is born with their genes, and these do not change throughout their life. However, there may be some differences in how genes act at a young age. In general, most children who are being considered for psychiatric medications will be old enough that this won’t be an issue.
Another factor to take into consideration is that some medications are not approved by the FDA for pediatric populations. The healthcare provider should take the child’s age into consideration when interpreting the GeneSight Psychotropic test results.
95 percent of patients pay $330 or less for their GeneSight test. The GeneSight Promise is that if we determine your out-of-pocket cost to be greater than $330, we will contact you before processing the test.
Some government and commercial insurance companies cover the GeneSight test. You can ask questions about your coverage by calling our Customer Service team at 866.260.2394.
If you are uninsured, please call our Customer Service team to discuss how we can help at 866.260.2394.
If you have traditional Medicare or Medicaid plans, your out-of-pocket cost will be $0.
Yes, we take privacy and security very seriously. That’s why we analyze all GeneSight Psychotropic and GeneSight MTHFR tests at our own accredited lab, so we can ensure the quality and security of your test. Your genetic information is private and protected through various federal laws including HIPAA (Health Insurance Portability and Accountability Act) and GINA (Genetic Information Nondiscrimination Act) that ensure the security of your personal and genetic information.
All samples are destroyed within 60 days of processing. Patients can also request to have their samples destroyed immediately.
Once we receive your sample, we share the results with your healthcare provider in about two days.
Yes, you can request a copy of the report from the healthcare provider who ordered your GeneSight test. If that is not possible, our customer service team at 866.260.2394 can help.
Yes. You should start by asking your doctor to share the report with you and explain the results. You can also request a patient report form by emailing us at email@example.com or calling us at 866.260.2394.
Yes. The GeneSight test provides results that are 99.8 percent accurate about your specific genotype.
Yes, if your healthcare providers orders the GeneSight MTHFR test. The GeneSight MTHFR test checks for a gene variation which can predict your body’s ability to convert folic acid into its active form.
The GeneSight Psychotropic test is supported by clinical studies published in peer-reviewed journals. GeneSight Psychotropic is the only psychiatric pharmacogenomic test backed by such extensive research.